A detailed history of Los Angeles Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 417,053 shares of GILD stock, worth $38.6 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
417,053
Previous 678,989 38.58%
Holding current value
$38.6 Million
Previous $46.6 Million 24.96%
% of portfolio
0.14%
Previous 0.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$66.59 - $83.99 $17.4 Million - $22 Million
-261,936 Reduced 38.58%
417,053 $35 Million
Q2 2024

Aug 05, 2024

SELL
$63.15 - $72.88 $46.6 Million - $53.8 Million
-738,365 Reduced 52.09%
678,989 $46.6 Million
Q1 2024

Apr 05, 2024

SELL
$71.58 - $87.29 $1.41 Million - $1.72 Million
-19,677 Reduced 1.37%
1,417,354 $104 Million
Q4 2023

Feb 06, 2024

BUY
$73.27 - $83.09 $36.7 Million - $41.6 Million
501,105 Added 53.54%
1,437,031 $116 Million
Q3 2023

Nov 06, 2023

BUY
$73.94 - $80.67 $46.9 Million - $51.2 Million
634,659 Added 210.66%
935,926 $70.1 Million
Q2 2023

Aug 03, 2023

SELL
$76.01 - $86.7 $17.4 Million - $19.8 Million
-228,813 Reduced 43.17%
301,267 $23.2 Million
Q1 2023

May 04, 2023

SELL
$77.31 - $88.08 $136 Million - $155 Million
-1,755,157 Reduced 76.8%
530,080 $44 Million
Q4 2022

Feb 06, 2023

BUY
$62.32 - $89.47 $9.69 Million - $13.9 Million
155,507 Added 7.3%
2,285,237 $196 Million
Q3 2022

Nov 02, 2022

BUY
$59.54 - $68.01 $9.25 Million - $10.6 Million
155,376 Added 7.87%
2,129,730 $131 Million
Q2 2022

Aug 05, 2022

SELL
$57.72 - $65.01 $441,788 - $497,586
-7,654 Reduced 0.39%
1,974,354 $122 Million
Q1 2022

May 06, 2022

BUY
$57.92 - $72.58 $43.6 Million - $54.6 Million
752,594 Added 61.22%
1,982,008 $118 Million
Q4 2021

Feb 03, 2022

BUY
$64.88 - $73.64 $41.6 Million - $47.2 Million
641,141 Added 108.99%
1,229,414 $89.3 Million
Q3 2021

Nov 08, 2021

SELL
$67.69 - $73.03 $8.27 Million - $8.92 Million
-122,198 Reduced 17.2%
588,273 $41.1 Million
Q2 2021

Aug 05, 2021

SELL
$63.47 - $69.35 $5.54 Million - $6.06 Million
-87,329 Reduced 10.95%
710,471 $48.9 Million
Q1 2021

May 05, 2021

BUY
$60.0 - $68.46 $19.2 Million - $21.9 Million
320,409 Added 67.12%
797,800 $51.6 Million
Q4 2020

Feb 04, 2021

SELL
$56.65 - $64.55 $6,401 - $7,294
-113 Reduced 0.02%
477,391 $27.8 Million
Q3 2020

Nov 02, 2020

BUY
$62.1 - $78.08 $5.27 Million - $6.63 Million
84,916 Added 21.63%
477,504 $30.2 Million
Q2 2020

Aug 05, 2020

BUY
$72.34 - $84.0 $17.3 Million - $20.1 Million
239,647 Added 156.69%
392,588 $30.2 Million
Q1 2020

May 04, 2020

SELL
$62.63 - $80.22 $22.2 Million - $28.4 Million
-353,974 Reduced 69.83%
152,941 $11.4 Million
Q4 2019

Feb 07, 2020

BUY
$61.62 - $67.78 $5.46 Million - $6.01 Million
88,599 Added 21.18%
506,915 $32.9 Million
Q3 2019

Nov 07, 2019

SELL
$62.51 - $69.0 $101,703 - $112,263
-1,627 Reduced 0.39%
418,316 $26.5 Million
Q2 2019

Jul 29, 2019

SELL
$61.87 - $69.38 $12.1 Million - $13.6 Million
-196,105 Reduced 31.83%
419,943 $28.4 Million
Q1 2019

Apr 25, 2019

SELL
$62.53 - $70.05 $51.1 Million - $57.3 Million
-817,276 Reduced 57.02%
616,048 $40 Million
Q4 2018

Feb 11, 2019

BUY
$60.54 - $79.0 $54.6 Million - $71.3 Million
901,998 Added 169.76%
1,433,324 $89.7 Million
Q3 2018

Nov 05, 2018

SELL
$71.28 - $78.92 $33.2 Million - $36.8 Million
-466,330 Reduced 46.74%
531,326 $41 Million
Q2 2018

Jul 31, 2018

BUY
$64.88 - $75.68 $61 Million - $71.1 Million
940,044 Added 1631.68%
997,656 $70.7 Million
Q1 2018

Apr 27, 2018

SELL
$72.84 - $88.8 $36.6 Million - $44.7 Million
-502,974 Reduced 89.72%
57,612 $4.34 Million
Q4 2017

Feb 05, 2018

BUY
$71.15 - $83.52 $16.9 Million - $19.9 Million
237,987 Added 73.77%
560,586 $40.2 Million
Q3 2017

Nov 06, 2017

BUY
$72.11 - $85.47 $13.8 Million - $16.3 Million
190,898 Added 144.95%
322,599 $26.1 Million
Q2 2017

Aug 09, 2017

BUY
N/A
131,701
131,701 $9.32 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Los Angeles Capital Management LLC Portfolio

Follow Los Angeles Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.